A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
|
Nov 2013
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Standardized High-Sensitivity Flow Cytometry Testing for Paroxysmal Nocturnal Hemoglobinuria in Children with Acquired Bone Marrow Failure Disorders: A Single Center U.S. Study
|
Jun 2017
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications
|
Sep 2016
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
A Prospective Multicenter Study of Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure.
|
Oct 2013
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients
|
Jan 2015
|
Cytometry B Clin Cytom
|
myelodysplastic syndromes (MDS)
|
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes
|
May 2023
|
Current Treatment Options in Oncology
|
myelodysplastic syndromes (MDS)
|
Germline mutations in MDS/AML predisposition disorders
|
Mar 2021
|
Current opinion in hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents
|
Apr 2023
|
Current Hematologic Malignancy Reports
|
myelodysplastic syndromes (MDS)
|
Activin Receptor II Ligand Traps: New Treatment Paradigm for Low-Risk MDS
|
Jun 2019
|
Current Hematologic Malignancy Report
|
myelodysplastic syndromes (MDS)
|
Diagnosis and Treatment of Aplastic Anemia
|
Nov 2017
|
Curr Treat Options Oncol
|
aplastic anemia
|